Medicure Inc. (OTCMKTS:MCUJF – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.63 and traded as low as $0.50. Medicure shares last traded at $0.50, with a volume of 500 shares changing hands.
Medicure Price Performance
The stock has a fifty day moving average price of $0.52 and a 200-day moving average price of $0.63. The company has a market cap of $5.21 million, a PE ratio of -3.57 and a beta of 0.87. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.03 and a quick ratio of 1.64.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Featured Stories
- Five stocks we like better than Medicure
- How to Calculate Stock Profit
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Best Stocks Under $10.00
- 3 ETFs to Ride the VIX Surge During Market Volatility
- What to Know About Investing in Penny Stocks
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
